Cover Image
Market Research Report

Global Prils Market Research Report Forecast to 2023

Published by Market Research Future Product code 882308
Published Content info 109 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Prils Market Research Report Forecast to 2023
Published: June 30, 2019 Content info: 109 Pages
Description

Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, & the Middle East & Africa) - Global Forecast till 2023

Market analysis

The global prils market incorporates active pharmaceutical ingredients (APIs) fixings. APIs are naturally dynamic fixings or substances which are significant the piece of any medication. There are distinctive APIs accessible with various properties, and they are utilized by pharmaceutical, biotech, and nourishing enterprises appropriately to grow new items. The key variables in charge of driving the market are expanding the commonness of heart illnesses, hypertension and kidney related issues, rising geriatric populace, developing the significance of nonexclusive medications, and furthermore the general take-up of the biopharmaceuticals business. Notwithstanding, factors, for example, negative medication cost-control arrangements in numerous nations, expanding infiltration of fake medications, and complex permit reestablishment systems hamper the market development. The global prils market is anticipated to grow at CAGR of 4.3% to reach the valuation of USD 2,591.5 million till the year 2023.

Market segmentation

The global prils market is segmented on the basis of its type, application, and regional demand. Based on its type, the global prils market is categorized into Quinapril, Ramipril, Benazepril, and Cilazapril. The global prils market is segmented on the basis of its application, is divided into heart failure, hypertension, chronic kidney disorders, and others.

Regional analysis

Geographically, the global prils market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, among others are some of the major players in the global prils market.

Table of Contents

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Scope of the Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Growing Pharmaceutical Industry
    • 4.2.2 Growing Prevalence of Chronic Diseases Across the World
    • 4.2.3 Growing Importance of Generic Drugs
  • 4.3 Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 Adverse Drug Price Control Policies Across Numerous Countries
  • 4.4 Opportunity
    • 4.4.1 Development of New Drugs
  • 4.5 Product Pipeline Analysis
    • 4.5.1 Introduction
    • 4.5.2 NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
    • 4.5.3 Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
    • 4.5.4 Ramipril Treatment of Claudication
    • 4.5.5 Bariatric Surgery and Pharmacokinetics of Ramipril

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Marketing & Sales
    • 5.1.5 Post-Sales Review
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.5 Intense Rivalry
  • 5.3 Specifications & Purity Requirements
  • 5.4 Patent Analysis
    • 5.4.1 Introduction
    • 5.4.2 Patent Analysis for Benazepril
      • 5.4.2.1 Process for Preparation of Benazepril
    • 5.4.3 Patent Analysis for Cilazapril
      • 5.4.3.1 Process for Preparation of Enantiomerically Pure Cilazapril
      • 5.4.3.2 Process for the Preparation of Cilazapril
      • 5.4.3.3 Process for the Preparation of an Intermediate of Cilazapril
    • 5.4.4 Patent Analysis of Quinapril
      • 5.4.4.1 Methods for the Preparation of Quinapril
      • 5.4.4.2 Methods for the Preparation of Quinapril Hydrochloride
      • 5.4.4.3 Process for the Preparation of Highly Pure Crystalline Quinapril Hydrochloride
      • 5.4.4.4 Formulations of Quinapril and Related Ace Inhibitors
    • 5.4.5 Patent Analysis for Ramipril
      • 5.4.5.1 Formulations of Ramipril
      • 5.4.5.2 Stabilized Individually Coated Ramipril Particles, Compositions, and Methods
      • 5.4.5.3 Use of Ramipril in the Prevention of Congestive Heart Failure
  • 5.5 Regulatory Analysis
  • 5.6 Pricing Evolution

6 Global Prils Market, by Type

  • 6.1 Introduction
  • 6.2 Ramipril
  • 6.3 Quinapril
  • 6.4 Cilazapril
  • 6.5 Benazepril

7 Global Prils Market, by Application

  • 7.1 Introduction
  • 7.2 Hypertension
  • 7.3 Heart Failure
  • 7.4 Chronic Kidney Disorders

8 Global Prils Market, by Region

  • 8.1 Introduction
  • 8.2 Americas
    • 8.2.1 North America
      • 8.2.1.1 US
      • 8.2.1.2 Canada
    • 8.2.2 South America
  • 8.3 Europe
    • 8.3.1 Western Europe
      • 8.3.1.1 Germany
      • 8.3.1.2 UK
      • 8.3.1.3 France
      • 8.3.1.4 Italy
      • 8.3.1.5 Spain
      • 8.3.1.6 Rest of Western Europe
      • 8.3.1.7 Eastern Europe
  • 8.4 Asia-Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 Middle East & Africa
    • 8.5.1 Middle East
    • 8.5.2 Africa

9 Competitive landscape

  • 9.1 Introduction
  • 9.2 Key developments

10 Company Profiles

  • 10.1 Aurobindo Pharma
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 Lupin
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products/Services Offered
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 Pfizer, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products/Services Offered
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 Mylan N.V.
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 F. Hoffmann-La Roche
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Sun Pharmaceutical Industries Ltd
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products/Services Offered
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 Merck KGaA
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies
  • 10.8 Manus Aktteva Biopharma LLP
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products/Services Offered
    • 10.8.4 Key Developments
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Strategies
  • 10.9 Canagen Pharmaceuticals Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products/Services Offered
    • 10.9.4 Key Developments
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Strategies
  • 10.1 Novartis AG
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Products/Services Offered
    • 10.10.4 Key Developments
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Strategies

11 Appendix

References

Related Reports

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 PRILS MARKET: PRODUCT PIPELINE ANALYSIS
  • TABLE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET
  • TABLE 5 PATENT ANALYSIS FOR BENAZEPRIL
  • TABLE 6 PATENT ANALYSIS FOR CILAZAPRIL
  • TABLE 7 PATENT ANALYSIS FOR QUINAPRIL
  • TABLE 8 PATENT ANALYSIS FOR RAMIPRIL
  • TABLE 9 AMERICAS: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
  • TABLE 10 EUROPE: AVERAGE SELLING PRICE (ASP) ,BY TYPE, (USD/KG) 2018
  • TABLE 11 ASIA-PACIFIC: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
  • TABLE 12 MIDDLE EAST: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
  • TABLE 13 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 14 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 15 GLOBAL PRILS MARKET, FOR RAMIPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 16 GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 17 GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 18 GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 19 GLOBAL PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 20 GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 21 GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 22 GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 23 GLOBAL PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 24 AMERICAS: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 25 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 26 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 27 AMERICAS: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 30 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 31 NORTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 32 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 33 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 34 US: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 35 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 36 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 37 CANADA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 38 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 39 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 40 SOUTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 41 EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 42 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 43 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 44 EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 48 WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 49 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 50 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 51 GERMANY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 52 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 53 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 54 UK: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 55 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 56 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 57 FRANCE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 58 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 59 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 60 ITALY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 61 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 62 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 63 SPAIN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 64 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 65 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 66 REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 67 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 68 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 69 EASTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 70 ASIA-PACIFIC: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 71 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 72 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 73 ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 74 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 75 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 76 JAPAN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 77 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 78 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 79 CHINA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 80 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 81 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 82 INDIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 83 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 84 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 85 AUSTRALIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 86 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 87 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 88 SOUTH KOREA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 89 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 90 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 91 REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 95 MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 96 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 97 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 98 MIDDLE EAST: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 99 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
  • TABLE 100 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
  • TABLE 101 AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
  • TABLE 102 MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET
  • TABLE 103 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PRILS MARKET: STRUCTURE
  • FIGURE 3 RESEARCH PROCESS
  • FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES
  • FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET
  • FIGURE 6 VALUE CHAIN: GLOBAL PRILS MARKET
  • FIGURE 7 GLOBAL PRILS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL PRILS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
  • FIGURE 9 GLOBAL PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 10 AMERICAS: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 11 NORTH AMERICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 12 EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 13 WESTERN EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 14 ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 15 MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 16 CATEGORY WISE SHARE OF KEY DEVELOPMENTS
Back to Top